Bill To Boost Medical Research Comes With A CatchJuly 10, 2015 |
“That [goal] sounds pretty good,” Avorn says. But he says the bill is “loaded with a lot of provisions that were heavily influenced by pharmaceutical and biotech and medical device lobbyists that really do some pretty worrisome things.”
Quick Read
US Congress Moves to Block Human-Embryo EditingJune 26, 2015 |
Spending bill would also require religious experts to review recommendations for reproductive technique
Quick Read
The FDA has not yet made a final decision. But by lending their heft to a campaign for the drug, the feminists won the support of much of the nonprofit women’s health community in Washington, galvanizing it with the charge that a refusal to approve the drug would be sexist
Quick Read
New Blood-Donor Policy, Same Gay StigmaMay 22, 2015 |
LAST week, the Food and Drug Administration released highly anticipated draft recommendations that would allow gay men to donate blood after one year of celibacy. While an improvement from the current, highly criticized lifetime ban, the new policy, which was announced in December, still caters to fear and stigma rather than science. It should be reconsidered
Quick Read
In a move that may have broad ramifications for the pharmaceutical industry, a small drug maker called Amarin AMRN -6.57% has filed a lawsuit against the FDA to argue that its right to distribute information about unapproved uses of a medicine is protected by the First Amendment
Quick Read
Company Creates Bioethics Panel on Trial DrugsMay 7, 2015 |
Johnson & Johnson has appointed Arthur Caplan, a nationally known bioethicist, to create a panel that will make decisions about patients’ requests for potentially lifesaving medicine, responding to an emotional debate over whether companies should allow desperately ill people to have access to the drugs before they are approved
Quick Read
Homeopathic OversightApril 22, 2015 |
In the wake of new evidence of ineffectiveness and potential risks, the FDA is considering changing the way it regulates homeopathic drugs
Read More
FDA Ponders Putting Homeopathy To A Tougher TestApril 20, 2015 |
In 1988, the Food and Drug Administration decided not to require homeopathic remedies to go through the same drug-approval process as standard medical treatments. Now the FDA is revisiting that decision. It will hold two days of hearings this week to decide if homeopathic remedies should have to be proven safe and effective
Quick Read
